Please login to the form below

Not currently logged in
Email:
Password:

ICON to open global innovation hub in Ireland

Will create 200 new jobs
 Ireland flag

ICON has revealed plans to open a global innovation hub in Ireland that will focus on the development of new technologies and clinical trial processes.

The firm, which provides outsourced development services to the pharma, biotech and medical device industries, will aim for the developments to enable faster access to large volumes of clinical data and ensure a better insight from data.

Ciaran Murray, CEO of ICON, commented: “We have successfully built relationship with all of the world's top biopharma companies and have been at the forefront of innovation in the design and conduct of global clinical trials.

“As innovation plays an increasingly important role in improving the outcomes of clinical trials, we are excited to reinforce our commitment to that goal by locating our global innovation hub in Ireland, one of the leading R&D and innovation centres in the world.”

It is thought that the opening of the hub will create 200 new jobs including positions in IT, data analytics, clinical science, project management, finance and human resources.

The project has been part-funded by the Department of Jobs, Enterprise and Innovation through Enterprise Ireland.

Julie Sinnamon, CEO of Enterprise Ireland, added: “I warmly welcome this exciting new investment which will expand Ireland's capabilities in the field of data analytics and 'Big Data' management in the life sciences sector and wish ICON continued success for the future.”

 

Article by
Kirstie Pickering

2nd February 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics